Clinical Trials Directory

Trials / Completed

CompletedNCT03761394

Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke

Smartwatch Monitoring for Atrial Fibrillation After Stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
University of Massachusetts, Worcester · Academic / Other
Sex
All
Age
50 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The goal of this research study is to develop a smartphone application capable of monitoring paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient ischemic attack (TIA) or people who are at risk for a stroke and are age 50 and older. The study team plans to develop a highly effective and easy to use cardiovascular surveillance system to monitor patients for pAF on a nearly continuous basis. People involved in the development of this system include patients, their caregivers, health care providers, and computer programmers.

Conditions

Interventions

TypeNameDescription
DEVICETesting DevicesPulsewatch system testing application on smartphone with smartwatch.
DEVICECardea Solo by Cardiac InsightGold-standard cardiac monitor for comparison of testing devices.
DEVICEKardia Mobile by AliveCorMobile ECG device for comparison of testing devices during the extended use period.

Timeline

Start date
2019-09-03
Primary completion
2021-09-20
Completion
2021-09-20
First posted
2018-12-03
Last updated
2023-11-18
Results posted
2023-11-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03761394. Inclusion in this directory is not an endorsement.